Presentation ACC 2021 Benefits of SGLT1/2 Inhibition with Sotagliflozin in Heart Failure With Preserved Ejection Fraction Presenter: Deepak L. Bhatt May 17, 2021 REGISTER for free or LOG IN to view this content Heart Failure Presentation ACC 2021 SGLT1/2 sotagliflozin Up Next Presentation ACC 2021 Effect of a Hospital and Post-discharge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction Presenter: Adam DeVore May 17, 2021 More slides + Presentation ACC 2021 Randomized trial of high sensitivity Troponin T in the Emergency Department Presenter: Derek Chew May 18, 2021 Presentation TVT 2021 Angel's Envy is Not Your Friend Presenter: Luke Alquizola July 20, 2021 We Recommend
Presentation ACC 2021 Effect of a Hospital and Post-discharge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction Presenter: Adam DeVore May 17, 2021
Presentation ACC 2021 Randomized trial of high sensitivity Troponin T in the Emergency Department Presenter: Derek Chew May 18, 2021